Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Evaluation of large language model-generated medical information on idiopathic pulmonary fibrosis
1
Zitationen
10
Autoren
2025
Jahr
Abstract
Background: Idiopathic Pulmonary Fibrosis (IPF) information from AI-powered large language models (LLMs) like ChatGPT-4 and Gemini 1.5 Pro is unexplored for quality, reliability, readability, and concordance with clinical guidelines. Research question: What is the quality, reliability, readability, and concordance to clinical guidelines of LLMs in medical and clinically IPF-related content? Study design and methods: < 0.05. Results: = 0.0029). Interpretation: Both models gave useful medical insights, but their reliability is limited. Gemini 1.5 Pro gave greater quality information than ChatGPT-4 and was more compliant with worldwide IPF guidelines. Readability analyses found that AI-generated medical information was difficult to understand, stressing the need to refine it. What is already known on this topic: Recent advancements in AI, especially large language models (LLMs) powered by natural language processing (NLP), have revolutionized the way medical information is retrieved and utilized. What this study adds: This study highlights the potential and limitations of ChatGPT-4 and Gemini 1.5 Pro in generating medical information on IPF. They provided partially reliable information in their responses; however, Gemini 1.5 Pro demonstrated superior quality in treatment-related content and greater concordance with clinical guidelines. Nevertheless, neither model provided answers in full concordance with established clinical guidelines, and their readability remained a major challenge. How this study might affect research practice or policy: These findings highlight the need for AI model refinement as LLMs evolve as healthcare reference tools to help doctors and patients make evidence-based decisions.
Ähnliche Arbeiten
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
2011 · 7.244 Zit.
Interpretative strategies for lung function tests
2005 · 5.941 Zit.
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
2019 · 5.188 Zit.
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
2014 · 4.567 Zit.
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
2010 · 4.499 Zit.
Autoren
Institutionen
- Universidad de Especialidades Espíritu Santo(EC)
- Humboldt-Universität zu Berlin(DE)
- Freie Universität Berlin(DE)
- Charité - Universitätsmedizin Berlin(DE)
- University of Freiburg(DE)
- University Medical Center Freiburg(DE)
- Hospital Regional de Alta Especialidad del Bajío(MX)
- Universidade Estadual de Feira de Santana(BR)
- University of British Columbia(CA)